Dublin, Jan. 27, 2025 (GLOBE NEWSWIRE) — The “Plasmid Purification Market by Product & Service, by Grade, by Application, by End-User, and By Region” report has been added to ResearchAndMarkets.com’s offering.
The global Plasmid Purification Market size was estimated to be USD 1.96 billion in 2023 and is expected to reach USD 6.59 billion by 2034 with a CAGR of 11.63% during the forecast period 2024-2034
Rising demand for gene therapies and biologics, advances in biotechnology, increased investments in R&D, biopharmaceutical manufacturing expansion, and increased awareness and use of personalized medicine will all fuel market growth.
Innovations in purification technologies, such as affinity chromatography and membrane-based systems, enhance the efficiency and yield of plasmid extraction, facilitating easier scalability and quality improvement, which are essential for meeting the growing needs in the gene therapy sector.
For instance, in August 2023, CD Bioparticles launched a new line of DNA extraction and purification kits designed for rapid and reliable isolation of various DNA types, which further underscores the market’s evolution and response to technological advancements. As these innovations progress, the market’s potential for growth is reinforced by the ongoing demand for high-quality plasmid DNA in research and therapeutic applications.
North American region is anticipated for the highest revenue share during the forecast period owing to the presence of a well-established biotechnology and pharmaceutical industry, extensive research and development activities, and significant investment in advanced healthcare solutions.
Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rapid expansion of the biotechnology and pharmaceutical industries, coupled with increasing investments in research and development. For instance, in June 2024, Asahi Kasei Group’s U.S. subsidiary Bionova Scientific (a biologics CDMO) announced plans to establish a new plasmid DNA development and production plant in Texas.
By product and services, the Instrument segment accounted for the highest revenue-grossing segment in the global plasmid purification market in 2023 owing to the increasing demand for advanced purification technologies that enhance efficiency, yield, and automation in plasmid isolation processes. For example, in June 2024, Thermo Fisher Scientific, Inc. launched the KingFisher PlasmidPro Maxi Processor (PlasmidPro), a maxi-scale plasmid DNA purification system based on the company’s KingFisher instrument series.
Additionally, the services segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing complexity of plasmid purification processes and the growing demand for outsourced services among biotechnology and pharmaceutical companies.
By Grade, the molecular-grade segment accounted for the highest revenue-grossing segment in the global plasmid purification market in 2023 owing to the increasing demand for high-purity plasmid DNA required for critical applications in gene therapy, vaccine development, and recombinant protein production. For instance, in February 2023, AccuraBio collaborated with Cytiva to develop its plasmid DNA CDMO services, which utilize Cytiva’s bacterial plasmid two-step purification technology.
Additionally, the transfection grade segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing applications of plasmid DNA in gene editing, cell-based assays, and therapeutic developments that require efficient transfection processes.
By application, the cloning and protein expression segment accounted for the highest revenue-grossing segment in the global plasmid purification market in 2023 owing to the increasing demand for recombinant proteins in therapeutic and diagnostic applications, as well as the expanding use of plasmids in genetic engineering and synthetic biology. For instance, in April 2024, Charles River Laboratories negotiated a manufacturing agreement with Axovia Therapeutics and Ship of Thesus. Charles River will produce the gene-of-interest plasmid to enable Axovia’s gene treatments for ciliopathies.
Additionally, the transfection & gene editing segment is predicted to grow at the fastest CAGR during the forecast period owing to the surging advancements in gene editing technologies such as CRISPR/Cas9 and the increasing adoption of these methods in research and therapeutic applications.
By end-user, the academic and research institutes segment accounted for the highest revenue-grossing segment in the global plasmid purification market in 2023 owing to the significant increase in funding for research projects and the growing emphasis on biotechnology and life sciences education.
For instance, in June 2023, GenScript Biotech Corporation added the AmMag Quatro automated plasmid purification system to its lab and research product line, which may be utilized for viral vector creation for cell engineering and gene therapy. Additionally, the contract research organizations (CROs) segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing trend of outsourcing research and development activities by pharmaceutical and biotechnology companies.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Product and Services, Grade, Application, and End-User
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
- 20% Free Customization Available to Meet Your Exact Requirement.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 200 |
| Forecast Period | 2023 – 2034 |
| Estimated Market Value (USD) in 2023 | $1.96 Billion |
| Forecasted Market Value (USD) by 2034 | $6.59 Billion |
| Compound Annual Growth Rate | 11.6% |
| Regions Covered | Global |
Market Environment Analysis
- Porter’s 5 Forces Analysis
- PESTEL Analysis
- SWOT Analysis
Market Dynamics
- Drivers Analysis
- Restraints Analysis
- Opportunities Analysis
- Threats Analysis
- Trend Analysis
Competitor Analysis
- Qiagen
- Thermo Fisher Scientific
- Promega Corporation
- Merck KGaA (MilliporeSigma)
- Bio-Rad Laboratories
- New England Biolabs
- Takara Bio
- Zymo Research
- Macherey-Nagel
- Sangon Biotech
- GenScript
- Abcam
- Bioneer Corporation
- Invitrogen (part of Thermo Fisher)
- Genomed
Plasmid Purification Market Analysis & Forecast by Product and Services 2023 – 2034 (Revenue USD Bn)
- Instruments
- Kits & Reagents
- Services
Plasmid Purification Market Analysis & Forecast by Grade 2023 – 2034 (Revenue USD Bn)
- Molecular Grade
- Transfection Grade
Plasmid Purification Market Analysis & Forecast by Application 2023 – 2034 (Revenue USD Bn)
- Cloning & Protein Expression
- Transfection & Gene Editing
- Others
Plasmid Purification Market Analysis & Forecast by End-User 2023 – 2034 (Revenue USD Bn)
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations
Plasmid Purification Market Analysis & Forecast by Region 2023 – 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
For more information about this report visit https://www.researchandmarkets.com/r/z7ak98
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Global Plasmid Purification Market
